Glycyl-L-histidyl-L-lysine, an intricate peptide compound, has enticed the attention of the biomedical realm. The scientific community has rigorously scrutinized its promising utilization in mitigating cardiovascular afflictions, namely hypertension and atherosclerosis. Pioneering hypotheses suggest that this enigmatic entity might operate by orchestrating blood pressure fluctuations and fostering the expanse of vascular well-being. Moreover, ongoing scientific investigations endeavor to unravel the entire gamut of its therapeutic capacities in effectively managing assorted cardiovascular maladies.
CAT# | R2012 |
CAS | 49557-75-7 |
Chemical Name | (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid |
M.F/Formula | C14H24N6O4 |
M.W/Mr. | 340.38 |
Appearance | Solid |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
BIO 1211, is a non-covalent, small-molecule, cyclohexanecarboxylic acid base compound, tight-binding inhibitor ( ...
Discovery and Structure Calcitonin, also called thyrocalcitonin, a protein hormone synthesized and secreted in humans and oth ...
GR 94800, is a linear heptapeptide with the structure of PhCO-Ala-Ala-D-Trp-Phe-D-Pro-Nle Amide, which is a high ...
Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...
Icatibant, sold under the trade name Firazyr, is a plasma kallikrein inhibitor and the bradykinin B2 receptor an ...